This site is intended for health professionals only
Tuesday 25 September 2018
Share |

Topic: *** Editor's Pick

September 21, 2018
Northern Ireland-based critical care pharmacist Lorna Morrow explains why she decided to move from a community pharmacy setting to hospital

Northern Ireland-based critical care pharmacist Lorna Morrow explains why she decided to move from a community pharmacy setting to hospital
 
I qualified as a pharmacist in 2003 and honestly never initially dreamed that I’d end up working as a hospital pharmacist, as I was very settled in my role as a community pharmacist manager.
 

September 7, 2018
‘Hard look’ at gender parity needed as pharmacy’s female workforce set to grow

A ‘hard look’ at gender parity issues will be vital as the proportion of women working in pharmacy increases, a representative body for the sector has warned.
 

September 7, 2018
Pharmacists’ potential to empower female carers ‘overlooked’, report says

Pharmacists could do more to empower female carers, a representative body for the sector has urged.
 

September 7, 2018
Six in 10 pharmacy professionals in favour of banning homeopathy prescribing

Six in 10 pharmacy professionals are against the sale and dispensing of homeopathic products, pharmacists at an international conference have heard.

September 7, 2018
Why I love being a consultant pharmacist for the care of older people

Along with a varied and rewarding pharmacy career, I have enjoyed the last 22 years caring for older people living in community and care home settings.  My greatest motivation and the essence of my role is improving the outcomes and experience of older people through the best use of medicines. 
 

August 30, 2018
The European Commission has approved Vyxeos 44 mg/100mg powder for concentrate for solution for infusion for the treatment of adults with newly-diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes, manufacturer Jazz Pharmaceuticals has announced.

The European Commission has approved Vyxeos 44 mg/100mg powder for concentrate for solution for infusion for the treatment of adults with newly-diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes, manufacturer Jazz Pharmaceuticals has announced.
 
Vyxeos is an advanced liposomal formulation that delivers a synergistic molar ration of daunorubicin and cytarabine, Jazz Pharmaceuticals said.
 
The EC approval extends to all European member states as well as Iceland, Norway sand Liechtenstein.

August 30, 2018
Novartis UK Oncology statement on Novartis receiving European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)

Novartis UK Oncology statement on Novartis receiving European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)
 
"Today’s (27 August) approval by the European Commission of Kymriah® (tisagenlecleucel), the only CAR-T therapy licensed in two different types of blood cancers, moves us one step closer to providing this revolutionary therapy to appropriate patients in the UK. 
 
 
 

August 23, 2018
Kathy Oxtoby looks at the effects of antimicrobial resistance across Europe will be if it goes unchecked and investigates what should be done to tackle it

Kathy Oxtoby looks at the effects of antimicrobial resistance across Europe will be if it goes unchecked and investigates what should be done to tackle it
 
It may be a natural phenomenon, but antimicrobial resistance (AMR) has become a global health crisis of similar importance to infectious-disease pandemics, according to the World Health Organization (WHO).
 

August 23, 2018
Working as a pharmacist in the Central African Republic and the Democratic Republic of the Congo was a rewarding experience, despite considerable challenges, explains Barbara Pawulska

Working as a pharmacist in the Central African Republic and the Democratic Republic of the Congo was a rewarding experience, despite considerable challenges, explains Barbara Pawulska
 
What with busy dispensaries and tricky patients to contend with, life as a pharmacist can present challenges in any walk of the profession.
 

August 14, 2018
Only one third of pharmaceutical companies are compliant with Europan anti-counterfeiting measures, according to a representative group.

Only one third of pharmaceutical companies are compliant with Europan anti-counterfeiting measures, according to a representative group.
 
In a letter sent last week (6 August), the European Medicines Verification Organisation (EMVO) said that of the 2,291 pharmaceutical companies that have to connect to the European Medicines Verification System (EMVS) in less than six months, only 841 (36%) have signed the required agreement. 
 

August 14, 2018
The prescribing safety assessment (PSA) could benefit pre-registration pharmacy students who want to become independent prescribers, a study has concluded.

The prescribing safety assessment (PSA) could benefit UK pre-registration pharmacy students who want to become independent prescribers, a study has concluded.
 
The PSA is a 60-minute evaluation of 30 questions on writing and reviewing new prescriptions, calculating drug doses and identifying and avoiding adverse drug reactions and medication errors, among others.
 

August 8, 2018
Senior clinicians will be able to legally prescribe cannabis-derived medicines this autumn, the Home Office has announced.

Senior clinicians will be able to legally prescribe cannabis-derived medicines this autumn, the UK's Home Office has announced.
 

August 8, 2018
New restricted indications on prescribing Esmya (ulipristal acetate) for symptoms of uterine fibroids have been put in place by the UK’s medicines watchdog

New restricted indications on prescribing Esmya (ulipristal acetate) for symptoms of uterine fibroids put in place by the UK’s medicines watchdog now replace instructions that the drug should not be prescribed to any new patients.
 

August 6, 2018
New patient groups with cancer-associated venous thromboembolism (VTE) could benefit from taking once-daily oral LIXIANA (edoxaban), a recent analysis has said.

New patient groups with cancer-associated venous thromboembolism (VTE) could benefit from taking once-daily oral LIXIANA (edoxaban), a recent analysis has said.
 
Manufacturer Daiichi Sankyo announced today (6 July) it had published a new analysis on the clinical presentation, course and outcome of bleeding events in Thrombosis and Haemostasis, and the associated tumour types from the Hokusai-VTE cancer study.
 

August 2, 2018
The Government should consider the economic as well as health benefits of vaccinating people against flu, according to research by a think tank

The Government should consider the economic as well as health benefits of vaccinating people against flu, according to research by a think tank.
 
Research by the International Longevity Centre – UK (ILC-UK) argued that flu can adversely affect productivity within the economy. The biggest economic benefit of vaccinating against the condition is the reduction of lost employment and care giving costs, which total between £90m and £270m , it said.
 

August 1, 2018
More than 3000 participants from 75 countries gathered in Gothenburg for the 23rd congress of EAHP. The meeting covered a range of hospital pharmacy activities and highlights included biosimilars in oncology, advanced therapy medicinal products and post-operative analgesia
Anna de Goede
Anna de Goede
 
Richard Langford
Richard Langford
 
Eric Viel
Eric Viel
July 31, 2018
Delivering a clinical pharmacy service within an NHS acute trust has many challenges, not least of which is the conflict between workload demands and staffing resource.

Abstract

Aims

The clinical pharmacy services leads at Manchester University NHS Foundation Trust (Wythenshawe site) have designed and implemented a service delivery model utilising a pharmacy digital tracker board and workforce management system that allocates staff based on patient risk and workload. The aim of this paper is to describe the flexible service model and examine outcome measures pre- and post-implementation.

 

Methods and results

July 31, 2018
Biologic patent expiry offers the potential for huge cost savings through the use of biosimilars, although newer biologics appear more clinically effective. Is it possible therefore to resolve the issue of cost versus efficacy?
July 26, 2018
Who is Matt Hanncock and what is his background?

Matt Hancock MP was appointed digital, culture, media and sport secretary in January 2018 having been a junior minister in the department since July 2016. He was first elected an MP in the 2010 general election in the West Suffolk constituency.
 
Before entering parliament, he worked as an economist at the Bank of England and as chief of staff to the shadow chancellor.
 
He has little health background, with no obvious links to the NHS.
 

July 26, 2018
How will Matt Hancock’s healthcare priorities benefit the NHS?

Last week, health and social care secretary Matt Hancock gave his first speech at West Suffolk Hospital where he revealed three key priorities for the NHS: technology, workforce and prevention.
 
Speaking before the Health and Social Care Committee yesterday, he also gave more information on the work he intends to do.
 
So what do the priorities mean for the health service?
 
Technology focus
 

July 26, 2018
Steve Wiliams explains why he loves working in the field of cancer care

Working with cancer patients can be tough at times as despite all the effective new treatments, many patients still have incurable diseases. But being an oncology pharmacist is an amazing job and I would not swap it for anything else. 
 

July 23, 2018
The introduction of dose banding and the recent publication of product specifications by NHS England have set the ball in motion for the introduction of licensed standardised chemotherapy doses, the benefits of which are discussed here
Chemotherapy is the single biggest service area-spend within NHS England specialised commissioning. In 2016/17, NHS England spent approximately £1.7 billion on the routine commissioning of chemotherapy, with drug costs accounting for the largest proportion (80%).1
 
July 18, 2018
Up to 42% of UK medicines may not be able to market their products in the European Union (EU) post-Brexit, a survey from the European Medicines Agency (EMA) has revealed.

Up to 42% of UK medicines may not be able to market their products in the European Union (EU) post-Brexit, a survey from the European Medicines Agency (EMA) has revealed.
 
The EMA said marketing authorisation holders for 58% of 693 centrally authorised products (CAPs) are on track to ensure they can continue to market their products once the UK leaves the EU in March 2019.
 

July 18, 2018
The UK’s National Health Service turned 70 this month, and while we celebrate the achievements of one of the nation’s most valuable institutions, it’s also the perfect opportunity to pinpoint the role that pharmacy has played in the NHS during those decades.

The role of pharmacists in the NHS has, unsurprisingly, evolved quite a bit since its inception. Growing from what was originally a supply service to become a clinical practice in hospitals, and with a range of new roles in primary care, pharmacists are now recognised as a valuable part of the multidisciplinary clinical team.
 

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine